$11.73
-0.02-0.17%
al cierre: Nov 14, 4:00 PM EST
$11.56
-0.17-1.44%
Pre-comercialización: 4:30 AM EST
Comments
Loading...
Orientación y previsiones
Integra Lifesciences emite una orientación sobre las ganancias por acción y los ingresos futuros, lo que ofrece a los inversores una idea de cuánto espera ganar la empresa en los próximos períodos.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
10/30/2025 | IART | Integra Lifesciences | Q4 | 2025 | $0.79 | $0.84 | $0.72 | $420.00M | $440.00M | $439.64M | |
10/30/2025 | IART | Integra Lifesciences | FY | 2025 | $2.19 | $2.24 | $2.21 | $1.62B | $1.64B | $1.67B | |
07/31/2025 | IART | Integra Lifesciences | FY | 2025 | $2.19 | $2.29 | $2.24 | $1.66B | $1.68B | $1.67B | |
07/31/2025 | IART | Integra Lifesciences | Q3 | 2025 | $0.40 | $0.45 | $0.58 | $410.00M | $420.00M | $418.90M | |
05/05/2025 | IART | Integra Lifesciences | Q2 | 2025 | $0.40 | $0.45 | $0.57 | $390.00M | $400.00M | $417.04M | |
05/05/2025 | IART | Integra Lifesciences | FY | 2025 | $2.19 | $2.29 | $2.46 | $1.65B | $1.72B | $1.68B | |
02/25/2025 | IART | Integra Lifesciences | Q1 | 2025 | $0.40 | $0.45 | $0.56 | $375.00M | $385.00M | $411.71M | |
02/25/2025 | IART | Integra Lifesciences | FY | 2025 | $2.41 | $2.51 | $2.51 | $1.65B | $1.72B | $1.71B | |
11/04/2024 | IART | Integra Lifesciences | FY | 2024 | $2.41 | $2.49 | $2.45 | $1.61B | $1.62B | $1.61B | |
11/04/2024 | IART | Integra Lifesciences | Q4 | 2024 | $0.81 | $0.89 | $0.87 | $441.00M | $451.00M | $448.47M | |
07/29/2024 | IART | Integra Lifesciences | Q3 | 2024 | $0.36 | $0.44 | $0.85 | $372.00M | $382.00M | $432.11M | |
07/29/2024 | IART | Integra Lifesciences | FY | 2024 | $2.41 | $2.57 | $3.04 | $1.61B | $1.63B | $1.68B | |
05/06/2024 | IART | Integra Lifesciences | FY | 2024 | $3.01 | $3.11 | $3.19 | $1.67B | $1.69B | $1.62B | |
05/06/2024 | IART | Integra Lifesciences | Q2 | 2024 | $0.60 | $0.65 | $0.75 | $411.00M | $416.00M | $395.80M | |
02/28/2024 | IART | Integra Lifesciences | FY | 2024 | $3.15 | $3.25 | $3.44 | $1.60B | $1.62B | $1.62B | |
02/28/2024 | IART | Integra Lifesciences | Q1 | 2024 | $0.53 | $0.57 | $0.74 | $360.00M | $365.00M | $380.89M | |
10/25/2023 | IART | Integra Lifesciences | FY | 2023 | $3.10 | $3.14 | $3.14 | $1.54B | $1.55B | $1.55B | |
10/25/2023 | IART | Integra Lifesciences | Q4 | 2023 | $0.89 | $0.93 | $0.78 | $397.00M | $403.00M | $387.12M | |
07/26/2023 | IART | Integra Lifesciences | Q3 | 2023 | $0.76 | $0.80 | $0.97 | $386.00M | $390.00M | $411.86M | |
07/26/2023 | IART | Integra Lifesciences | FY | 2023 | $3.10 | $3.18 | $3.12 | $1.55B | $1.56B | $1.56B | |
05/23/2023 | IART | Integra Lifesciences | Q2 | 2023 | $0.55 | $0.59 | $0.77 | $372.00M | $376.00M | $398.13M | |
04/26/2023 | IART | Integra Lifesciences | FY | 2023 | $3.43 | $3.51 | $3.48 | $1.60B | $1.62B | $1.61B | |
04/26/2023 | IART | Integra Lifesciences | Q2 | 2023 | $0.75 | $0.79 | $0.85 | $396.00M | $400.00M | $404.78M | |
02/22/2023 | IART | Integra Lifesciences | FY | 2023 | $3.43 | $3.51 | $3.52 | $1.60B | $1.62B | $1.62B | |
02/22/2023 | IART | Integra Lifesciences | Q1 | 2023 | $0.72 | $0.76 | $0.79 | $370.00M | $376.00M | $381.72M | |
01/25/2023 | IART | Integra Lifesciences | FY | 2022 | $3.34 | $3.38 | $3.30 | — | — | — | |
01/25/2023 | IART | Integra Lifesciences | Q4 | 2022 | $0.92 | $0.96 | $0.89 | — | — | — | |
01/10/2023 | IART | Integra Lifesciences | FY | 2022 | $3.33 | — | $3.30 | $1.56B | $1.56B | $1.56B | |
01/10/2023 | IART | Integra Lifesciences | Q4 | 2022 | $0.91 | — | $0.89 | $397.00M | $398.00M | $397.50M | |
10/26/2022 | IART | Integra Lifesciences | FY | 2022 | $3.29 | $3.33 | $3.15 | $1.55B | $1.56B | $1.56B | |
10/26/2022 | IART | Integra Lifesciences | Q4 | 2022 | $0.87 | $0.91 | $0.88 | $391.00M | $403.00M | $403.50M | |
08/24/2022 | IART | Integra Lifesciences | FY | 2022 | $3.12 | $3.20 | $3.24 | $1.55B | $1.57B | $1.57B | |
08/24/2022 | IART | Integra Lifesciences | Q3 | 2022 | $0.69 | $0.73 | $0.80 | $374.00M | $382.00M | $387.79M | |
07/27/2022 | IART | Integra Lifesciences | FY | 2022 | $3.21 | $3.29 | $3.31 | $1.56B | $1.57B | $1.59B | |
07/27/2022 | IART | Integra Lifesciences | Q3 | 2022 | $0.78 | $0.82 | $0.84 | $383.00M | $391.00M | $398.66M | |
04/27/2022 | IART | Integra Lifesciences | Q2 | 2022 | $0.78 | $0.82 | $0.80 | $392.00M | $400.00M | $394.32M | |
04/27/2022 | IART | Integra Lifesciences | FY | 2022 | $3.27 | $3.35 | $3.31 | $1.58M | $1.60B | $1.59B | |
02/23/2022 | IART | Integra Lifesciences | Q1 | 2022 | $0.67 | $0.71 | $0.73 | $357.00M | $365.00M | $378.50M | |
02/23/2022 | IART | Integra Lifesciences | FY | 2022 | $3.27 | $3.35 | $3.42 | $1.58B | $1.60B | $1.63B | |
01/11/2022 | IART | Integra Lifesciences | FY | 2021 | — | — | — | $1.54B | $1.54B | $1.54B | |
01/11/2022 | IART | Integra Lifesciences | Q4 | 2021 | — | — | — | $404.00M | $406.00M | $403.94M |
PREGUNTAS FRECUENTES
¿Cuál es la orientación más reciente de Integra Lifesciences (IART)?
La orientación más reciente para Integra Lifesciences (IART) se informó el octubre 30, 2025 para Q4 2025. La empresa proporcionó una guía de ganancias por acción en el rango de $0.79 a $0.84, en comparación con el EPS estimado de $0.72. Además, Integra Lifesciences pronosticó ingresos entre $0.42B y $0.44B para el trimestre.
Explora orientación y previsión sobre todos los valores.